Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
Background: We aimed to compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (r FSH) with respect to clinical outcomes and the development of ovarian hyperstimulation syndrome (OHSS) for patients with polycystic ovary syndrome (PCOS) treated with in vitro fert...
Main Authors: | Ayse Figen Turkcapar, Berna Seckin, Gogsen Onalan, Tulin Ozdener, Sertac Batioglu |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2013-01-01
|
Series: | International Journal of Fertility and Sterility |
Subjects: | |
Online Access: | http://www.ijfs.ir/article_45152_efb0ee8a85dcd7933348f4a4d2ebc63e.pdf |
Similar Items
-
Recombinant FSH Compared to Clomiphene Citrate as the First-Line in Ovulation Induction in Polycystic Ovary Syndrome Using Newly Designed Pens: A Randomized Controlled Trial
by: Batool Hossein-Rashidi, et al.
Published: (2016-05-01) -
Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
by: Didier Dewailly, et al.
Published: (2020-09-01) -
Welsh Onion Root (Allium fistulosum) Restores Ovarian Functions from Letrozole Induced-Polycystic Ovary Syndrome
by: Young Ho Lee, et al.
Published: (2018-10-01) -
Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)
by: Eser Sefik Ozyurek, et al.
Published: (2017-05-01) -
The relationship between male testosterone hormone and some female hormones in women with polycystic ovary syndrome (PCOS)
by: Dalal Abdul Hussain Kadium, et al.
Published: (2016-04-01)